Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer

Archives of Surgery

Volumn 135, Issue 1, 2000, Pages 81-87

  Wanebo, Harold J ^a   Glicksman, Arvin S ^a   Vezeridis, Michael P ^a   Clark, Jeffrey ^b   Tibbetts, Lawrence ^a   Koness, R James ^a   Levy, Audrey ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; ILEUS; INTESTINE INFARCTION; JEJUNOSTOMY; KIDNEY FAILURE; LIVER FAILURE; LYMPH NODE DISSECTION; MALE; NUTRITIONAL SUPPORT; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PNEUMONIA; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; SEPSIS; SPLEEN INFARCTION; STOMACH OBSTRUCTION; SURVIVAL RATE; TUMOR REGRESSION;

EID: 0033985637     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.135.1.81     Document Type: Article

References (25)

1. Hoffman JP, Weese JL, Solin LJ, et al. A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma. Am Surg. 1993;59:772-781.
2. Hoffman JP, Weese JL, Solin LJ, et al. A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg. 1995;169:71-78.
3. Hoffman JP, O'Dwyer P, Agarwal P, Salazar H, Ahmad N. Preoperative chemotherapy for localized pancreatic carcinoma. Cancer Suppl. 1996;78:592-597.
4. Evans DB, Byrd DR, Mansfield PF. Preoperative chemoradiotherapy for adenocarcinoma of the pancreas: rationale and techniques. Am J Clin Oncol. 1991;14:359-364.
5. Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. 1992;127;1335-1339.
6. Evans DB, Abbruzzese J, Lee J, Cleary K, Rich T. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas (Abstract). Proc Am Soc Clin Oncol. 1994;13:226.
7. Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combine radiation and chemotherapy following curative resection. Arch Surg. 1985;120:899-903.
8. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer. 1987;59:2006-2010.
9. Ishikawa O, Ohigashi H, Imaoka S, et al. Concomitant benefit of preoperative irradiation in preventing pancreas fistula formation after pancreatoduodenectomy. Arch Surg. 1991;126:885-889.
10. Tepper J, Nardi G, Suit H. Carcinoma of the pancreas; review of MGH experience from 1963 to 1973: analysis of surgical failure and implications for radiation therapy. Cancer. 1976;37:1519-1524.
11. Pilepich MV, Miller HH. Preoperative irradiation in carcinoma of the pancreas. Cancer. 1980;46:1945-1949.
12. Kopelson G. Curative surgery for adenocarcinoma of the pancreas/ampulla of Vater: the role of adjuvant pre or post-operative radiation therapy. Int J Radiat Oncol Biol Phys. 1983;9:911-915.
13. Ishikawa O, Ohigashi H, Imaoka S, et al. Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? Arch Surg. 1994;129:1075-1080.
14. Weese JL, Nussbaum ML, Paul AR, et al. Increased resectability of locally advanced pancreatic and periampullary carcinoma with neoadjuvant chemoradiotherapy. Int J. Pancreatol. 1990;7:177-185.
15. Spitz FR, Abbruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol. 1997;15:928-937.
16. Wanebo HJ, Posner M. Glicksman A, et al. Integrated modality protocol for carcinoma of the pancreas; pilot program. Proc Am Soc Clin Oncol. 1991;10:158.
17. Ishikawa O, Ohigashi H, Teshima T, et al. Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreaticoduodenal region. J Surg Oncol. 1989;40:143-151.
18. Jessup JM, Colacchio T, Valone F, et al. Phase I/II neoadjuvant trial for locally advanced pancreas adenocarcinoma. Proc Am Soc Clin Oncol. 1993;12:201.
19. Rothenberg ML, Abbruzzese JL, Moore M. et al. A rationale for expanding the endpoints for clinical trials in advanced pancreatic cancer. Cancer Suppl. 1996; 78:627-632.
20. Rosvold E, Schilder R, Walczak J, et al. Phase II trial of PALA in combination with 5-fluorouracil in advanced pancreatic cancer. Cancer Chemother Pharmacol. 1992;29:305-308.
21. Hubbard KP, Pazdur R, Ajani JA, et al. Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer. Am J Clin Oncol. 1992 15:524-527.
22. Casper ES, Green MR, Kelsen DP, et al. Phase II trial of gemcitabine (2.2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest New Drugs. 1994;12:29-34.
23. Moore M, Anderson J, Burris H, et al. A randomized trial of gemcitabine (Gem) versus 5FU at first-line therapy in advanced pancreatic cancer. Proc Am Soc Clin Oncol. 1995, 14:199.
24. Rothenberg ML, Moore MJ, Cripps MC, et al. A phase II trial of gemcitabine in patients with 5-FU refractory pancreas cancer. Ann Oncol. 1996;7:347-353.
25. Safran H, King TP, Choy H, et al. Paclitaxel and concurent radiation for locally advanced pancreatic and gastric cancer: a phase I study. J Clin Oncol. 1997;15:901-907.